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Purpose: We have recently shown that nicotine and its metabolite cotinine are mitogenic 
for smooth muscle cells in vitro. In the present s udy, we examined the effect of nicotine 
and cotinine on the production of growth factors and the expression of matrix metallo- 
proteinases in smooth muscle cells. 
Methods: Smooth muscle cells were harvested from human arteries and grown in culture. 
Subconfluent cultures were incubated for 24 hours in M199 containing 0.1% fetal bovine 
serum with or without nicotine or cotinine at concentrations ranging from 10-9 mol /L  to 
10 -6 mol/L.  The supernatants and cell lysates were assayed by enzyme-linked immn- 
nosorbent assay for basic fibroblast growth factor (bFGF), tumor necrosis factor alpha 
(TNF-~), platelet-derived growth factor AB (PDGF-AB), and transforming rowth 
factor beta (TGF-~). Matrix metalloproteinase expression was determined in subcontin- 
ent cultures incubated in albumin with or without nicotine or cotinine at 10 -8 mol /L  and 
10 -7 mo l /L  for 6, 12, 18, 24 and 36 hours. Northern blot analyses were performed with 
human cDNA probes for collagenase-1, stromelysin-1, gelatinase A, gelatinase B, and 
triose phosphate isomerase. Blots were quantified by phosphor-imaging techniques. 
Results: Both nicotine and cotinine stimulated the production and secretion of bFGF in a 
dose-dependent manner. PDGF, TNF-eg and TGF-~ secretions were not significantly 
affected by nicotine or cotinine. Collagenase was up-regulated by nicotine at 18 and 24 
hours (4.5-fold to 5.8-fold) and by cotinine at 18 hours (from 5.0-fold to 29-fold). 
Stromelysin-1 was up-regulated by nicotine and cotinine at 12 and I8 hours (1.5-fold to 
7.0-fold). Gelatinase A generally peaked at 12 hours and was up-regulated by both agents 
(2.0-fold to 6.5-fold). 
Conclusion: Nicotine and cotinine enhanced the production of bFGF, a major mitogen for 
smooth muscle cells, and up-regulated the expression of several matrix metalloproteinases 
that are critical in cell migration. These data demonstrate mechanisms by which smoking 
may contribute to the development of intimal hyperplasia, atherosclerosis, and 
aneurysms. (J Vasc Surg 1996;24:927-35.) 
Development of intimal hyperplasia fter vessel 
wall injury is initiated by the activation and prolifera- 
tion of  smooth muscle ceils (SMCs) in the tunica 
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media. Subsequently, the SMCs migrate to the sub- 
endothelial space, where they proliferate and synthe- 
size the extracellular matrix (ECM). 1 Recent in vivo 
studies clarified the role o f  basic fibroblast growth 
factor (bFGF) and platelet-derived growth factor 
(PDGF) in the formation ofintimal esions; bFGF is 
essential for SMC proliferation, whereas PDGF pro- 
motes SMC migration to the subendothelial space. >s 
Cell migration is preceded by the breakdown of  the 
ECM by matrix metalloprotemases (MMPs). The 
major groups of MMPs are collagenases, tromel- 
ysins, and gelatinases. The collagenases digest colla- 
gen types I, I I ,  and I I I ,  whereas the stromelysins 
degrade collagen type IV, basal laminins, and base- 
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ment membranes. The gelatinases degrade denatured 
collagens or gelatins and collagen type IV. 4 
Several clinical and experimental studies have sug- 
gested that cigarette smoldng promotes the develop- 
ment of intimal hyperplasia, therosclerosis, and an- 
eurysms. ~-~s We have recently shown that nicotine 
and its metabolite cotinine promote human SMC 
proliferation in vitro. 16 We hypothesized that nico- 
tine and cotinine may increase the production of 
cytokines or may increase the sensitivity of SMCs for 
the growth factors that are present in serum. The 
current study was designed to investigate whether 
nicotine, cotinine, or both of these chemicals timu- 
late the production ofcytokines and affect he expres- 
sion of MMPs in SMCs in vitro. 
MATERIALS AND METHODS 
Materials. Nicotine and cotinine were pur- 
chased from Sigma Chemical Corp. (St. Louis). 
M199 medium and fetal bovine serum (FBS), vita- 
mins, minimal essential amino acids, penicillin-strep- 
tomycin mixture, gentamycin, trypsin, calcium, and 
magnesium-free Dulbecco's phosphate-buffered sa- 
fine solution (PBS) were obtained from Life Technol- 
ogies (Grand Island, N.Y.). Insulin, transferrin, and 
selenium mixture were obtained from Sigma. Mono- 
clonal antibodies against a and 13 actins were ob- 
tained from Sigma. Monoclonal antibody against yon 
Willebrand factor was purchased from Biogenex (San 
Roman, Calif.). Tissue culture dishes were obtained 
from Becton-Dicldnson (Lincoln Park, N.Y.). En- 
zyme-finked immunosorbent assay (ELISA) kits for 
human tumor necrosis factor alpha (TNF-~), human 
transforming rowth factor beta (TGF-13), human 
PDGF-AB, and bFGF were all obtained from R & D 
Systems (Minneapolis, Minn.). Human cDNA 
probes for triose phosphate isomerase (TPI), collage- 
nase-1 (CL-1), stromelysin-1 (STM-1), and gelati- 
nases A and B were previously described.17-2° Plasmid 
kit and the Qiaquick Gel Extraction lit were obtained 
from Qiagen (Chatsworth, Calif.). The nylon mem- 
branes and Genescreen membranes were from New 
England Nuclear (Boston). Agarose was purchased 
from FMC (Rockland, Me.). The 1-kilobase (kb) 
DNA ladder was from Life Technologies (Gathers- 
burg, Md.). 
Culture medium definition. Growth medium is 
defined as M199 containing 10% heat-inactivated 
FBS, 1% vitamins, 1% essential amino acid, 0.5% 
penicillin-streptomycin mixture, 0.02% gentamycin, 
5 ~g/ml insulin, 5 ~g/ml transferrin, and 0.005 
Ilg/ml selenium. No-growth medium contains 
M199 supplemented with 0.1% heat-inactivated FBS, 
0.5% penicillin-streptomycin mixture, and 0.02% 
gentamycin. Albumin medium is defined as M199 
containing 0.1% human albumin, 0.5% penicillin- 
streptomycin mixture and 0.02% gentamycin. 
Cell harvesting and characterization. SMCs 
were harvested using an explant echnique from mac- 
roscopically healthy human arteries that were ob- 
tained from cadaver donors. Thc cells were character- 
ized by their growth requirements, growth pattern, 
and by monoclonal antibody staining for SMC ~-ac- 
fin, 13-actin, and yon Willebrand factor. Cell passages 
2 to 6 were used in all described experiments. 
Growth factor studies. SMCs were plated in six 
multiwell dishes and grown to subconfluency in 
growth medium. For each set of experiments, one 
tray of six wells was used to determine the cell count. 
The cells for cytokine study were washed with PBS 
before incubating in 2 ml no-growth medium supple- 
mented with nicotine or cotinine at concentrations 
ranging from 10 .9 mol/L to 10 -6 mol/L for 24 
hours. Cells exposed to no-growth medium were 
used as control. At the end of the experiment, he 
conditioned medium was harvested. The SMCs were 
washed with PBS, removed from the plate by gentle 
scraping with a rubber policeman, added to a con- 
tainer with 2 ml M199, and sonicated to yield cell 
lysate. Supernatants and lysates were stored at 
-70°C until analyzed. ELISA kits for TGF-13, 
TNF-e~, bFGF, and PDGF-AB were used to analyze 
the supernatants and lysates. 
RNA preparations. SMCs were grown to sub- 
confluency with growth medium in T-150 culture 
dishes. The cells were washed with PBS and incu- 
bated for 6, 12, 18, 24, and 36 hours in albumin 
medium with or without nicotine or cotinine at 10 -7  
and 10 .8 mol/L. Subsequently, the cells were 
washed and lysed with 5 ml of GTC lysis solution 
(acid guanidium thiocyanate-phenol-chloroform) as 
previously described. 21The lysate was extracted with 
1 ml chloroform and RNA in the aqueous phase 
precipitated with a 70% volume of isopropanol, fol- 
lowed by resuspension i  100 ~1 of TE solution (10 
mmol/L Tris pH 7.5, 1 mmol/L ethylenediamine 
tetraacetic acid). RIgA quantitation was done by 
spectrophotometry at 260 nm. RNA samples were 
stored at -20  ° C until analyzed. RNA (10 txg) was 
electrophoresed on a 1.5% agarose-formaldehyde gel 
and then transferred to a nylon membrane overnight 
in 10x standard sodium chloride/saline citrate solu- 
tion. RNA was cross-linked to the membrane by 
ultraviolet radiation and baldng at 80 ° C for 2 hours. 
Probe preparation. Escherichia coli organisms 
transfected with a specific probe were obtained in 
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lyophilized form. The bacteria were grown on ampi- 
cillin agar plates for 18 to 24 hours. A single colony 
was used to inoculate 100 ml of Laura Broth contain- 
ing 40 Ixg/ml ampicillin. The culture flask was agi- 
tated for 18 to 24 hours at 37 ° C. After centrifuga- 
tion, the bacterial pellet was processed using the 
Qiagen Plasmid Prep kit. The plasmid DNA was 
eluted from the resin column with TE solution. Sub- 
sequently, 10 txl of plasmid DNA were incubated 
with one or more restriction endonucleases and the 
digest electrophoresed on a 0.8% agarose gel. A com- 
mercial DNA ladder was electrophoresed with the 
digests. Bands that fit the specification of  the desired 
probe were excised and processed with a Qiagen Gel 
Extraction Kit. The purified probe was eluted with 
TE and was stored at -20  ° C. A small portion of 
purified DNA was electrophoresed and quantified 
visually. Approximately 20 ng of probe cDNA was 
labeled with [32p] 0~-dATP for 1 to 4 hours at 37 ° C. 
Incorporation yield ranged between 30% and 80%. 
Hybridizat ion studies. The membrane was pre- 
hybridized in church buffer at 65 ° C and then hybrid- 
ized with the labeled probe overnight at 65 ° C. Sub- 
sequently, it was washed twice with blot wash 
solution (0.045 mol /L  NaC1, 0.0045 mol /L  sodium 
citrate, and 0.5% sodium dodecylsulfate) at 65 ° C. 
The membrane was first analyzed by autoradiography 
and then by phosphor-imaging (Molecular Dynam- 
ics, Sunnydale, Calif.) for quantitation. The mem- 
branes were sequentially probed with TP1, CL-1, 
STM-1, gelatinase A, and gelatinase B, Tris/sodium 
dodecylsulfate solution was used to strip the mem- 
branes between probes: The TPI probe was used to 
normalize loading. 
Statistical analysis. Results were analyzed by 
analysis of variance and Student's t test. A p value 
below 0.05 was considered statistically significant. 
RESULTS 
Characterization of  human SMC cultures. 
The cnltured cells were characterized asSMCs by a 
typical "hill and valley" growth pattern at confluency 
and positive immunostalning with anti-SMC ~-actin. 
No staining was observed with the antibody to yon 
Wlllebrand factor, demonstrating the absence of con- 
taminating endothelial cells in cultures. These obser- 
vations were consistent throughout the number of 
passages used in the experiments. 
Growth factor analysis. To evaluate the effect 
of nicotine and cotinine on the synthesis and secre- 
tion of the cytokines and growth factors, subconflu- 
ent cultures were exposed for 24 hours to either 
nicotine or cotinine dissolved in no-growth medium. 
Table I. TNF-0~ and PDGF-AB synthesized 
by SMCs exposed to nicotine and cotinine 
for 24 hours 
TNF-a  ~g/ml  PDGF AB ~tg/ml 
~mean ~- SEM; n = 3) (mean ~_ SEM," n = 4) 
Control  0.66 -~ 0.33 44.4 ~ 9.99 
Nicot ine 
10 -9 1.04 _~ 0.02 45.6 z 16.3 
10 -a  0.86 z 0.27 48.2 _+ 10.5 
10 -7 0.74 z 0.32 67.7 +-- 11.1 
10 -6 1.24 ~ 0.13 38.2 z 5.1 
Cofinine 
10 -9 0.74 _~ 0.24 37.5 _~ 1.4 
10 - s  0.76 x 0.22 55.6 -+ 13.5 
10 -7 0.64 x 0.32 75.8 x 13.5 
10 -6 0.99 -,- 0.14 40.3 z 0.7 
The approximate number of cells per well in each 
plate that were used in these experiments was 3.3 + 
0.15 × 105 (mean ~_ SEM). The supernatants and 
cell lysates were analyzed for TGFq3, TNF-c~, and 
bFGF using high sensitivity ELISA kits. The 
PDGF-AB assay was performed with a standard 
ELISA kit. 
TGF-~ was nor detected in the supernatants or
cell lysates in the control specimens or in the treated 
cultures. TNF-~ was found in very low quantities in 
the supernatants and the lysates, but it did not appear 
to be significantly influenced by the presence of nic- 
otine or cotinine (Table I). PDGF-AB was detected 
in both lysates and supernatants of the control cul- 
tures and the cells exposed to cotinine and mcotine, 
but only at concentrations that were closed to the 
lowest level of detectability ofthe assay. Nicotine and 
cotinine at a concentration f ]0  -7 mol /L  stimulated 
the overall production of PDGF-AB in SMC culture; 
however, the increase was not statistically significant 
(Table I). In contrast, bFGF was found in only the 
supernatants and followed a dose-response curve 
with both nicotine and cotinine. For nicotine, amax- 
imum effect (43.5 + 8.3 pg/ml) was observed at 
10 -8 tool/L,  representing a 2.88-fold increase over 
the control (p < 0.015 ). The maximum response for 
cotinine (34.0 + 4.8 pg/ml)  was observed at 10 -7 
mo l /L  concentration~ corresponding to a 2.25-fold 
increase~ver the control (Fig. 1). 
MMP analysis. The expression of MMP activity 
as a fianction of time was investigated in the control 
specimens, nicotine-treated SMCs, and cotinine- 
treated SMCs. The membranes were sequentially 
probed with TPI, CL-I~ STM-1, gelatinase A and 
gelatinase B. TPI was a 3.1 kb Ncol  fragment from 
human eDNA. The CL-1 probe was a Sal- 1 /H ind III 
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Fig. 1. bFGF found in conditioned medium of human 
SMCs after 24 hours of incubation with different concen- 
trations of nicotine or cotinine dissolved in no-growth 
medium. At the time indicated in the figure, supernatants 
were collected and stored frozen until analyzed with ELISA 
ldt. Values represent mean of four experiments, with SEM 
indicated by vertical bars. 
2.0 kb fragment. The STM-1 probe was a 1.8 kb 
Sma-1 fragment. Gelatinase A was a 2.9 kb Hind 
I I I /Sma- 1 fragment. Gelatinase B was a 2:3 kb Xba-1 
fragment from a human cDNA clone) 7-2~ 
CL-1 expression was increased in nicotine-stimu- 
lated and cotinine-stimulated cells. The quantitative 
analysis of the hybridized membrane by the phos- 
phor-imaging method revealed that CL-1 expression 
in the cells stimulated by nicotine at a concentration 
of  10 -7 mol /L  increased sixfold over the control at 
24 hours. Incubation of  SMCs with nicotine at a 
concentration f10 -s mo l /L  for 18 hours resulted in 
a 4.5-fold increase of  CL-1 expression (Fig. 2, A). 
For cotinine, amaximum effect was observed at 10 .7 
mol /L  after 18 hours incubation, representing a 
29-fold increase over the control (Fig. 2, B). STM-1 
messenger RNA expression peaked at 18 hours for 
both 10 -7 mol /L  and 10 -s mo l /L  nicotine concen- 
tration (2.8-fold and 3.2-fold increase, respectively) 
(Figs. 3, A and 4, A). The maximum expression of  
STM-1 was noticed for cotinine at 10 -s mo l /L  after 
12 hours incubation (sevenfold increase) (Figs. 3, B 
and 4, B). The expression of  gelatinase A Showed 
peaks at 12 and 24 hours in the presence of  nicotine 
at 10 -7 mol /L  and peaked at 12 hours in the pres- 
ence of  cotinine at 10 -8 mol /L  (Fig. 5, A and B). 
Gelatinase B was not detected in the control, nico- 
tine-stimulated or cotinine-stimulated cells (data not 
shown). 
DISCUSSION 
Decreased patency rates for aortic and infraingui- 
nal grafts, as well as an increased restenosis rates after 
carotid endarterectomy among cigarette smokers, 
have been well-documented but were often attrib- 
uted to the progression of  atherosclerosis and the 
alteration of blood coagulation rather than the devel- 
opment of  intimal hyperplasia, s,22 Recently, Law et 
al. 5 showed that inhalation of cigarette smoke en- 
hanced the development of intimal hyperplasia in an 
experimental rterial injury model in rats. Cigarette 
smoke contains a complex mixture of  several thou- 
sand chemicals, and it has been recognized that 
this mixture may cause injury to the vessel 
wall. ~7,9-12,23-27 However, it is still unclear which 
tobacco-derived products may be involved in the 
pathogenesis of intimal hyperplasia, nd the specific 
role of nicotine in this context has not yet been 
clarified. 
Nicotine levels in plasma peak within 10 minutes 
of the initiation of smoldng and range from 6.2 to 
19.0 X 10 -s mo l /L  in active smokers. 2s The elimi- 
nation half-life of nicotine is 2 hours. Cotinine is 
formed in the liver by oxidation of nicotine and has a 
biologic half-life of approximately 20 hours. The 
plasma concentration of cotinine in active smokers 
ranges from 5.9 to 15.0 X 10 -7 mol /L .  27,29 Inter- 
estingly, cotinine plasma concentrations in passive 
smokers can be as high as 3.6 to 11.0 x 10 -8 too l /  
L.27-29 
We have recently shown that both nicotine and 
cotinine stimulate SMC proliferation, but only in the 
presence of serum. 16 In addition, we reported that 
cotinine stimulates the release of endothelin from 
large-vessel ndothelial cells. ~4 Endothelin is a mito- 
gen for SMCs and promotes the development of  
intimal hyperplasia in an exPerimental rterial injury 
model. 3°,al In the present study, we examined the 
effect of  nicotine and cotinine on the production of  
bFGF, a potent mitogen and aia important factor for 
autocrine regulation of SMC proliferation. 2 Produc- 
tion of  bFGF in SMCs was stimulated by both nico- 
tine and cotinine in a. dose-dependent manner at 
concentrations seen among active and passive smok- 
ers. Interestingly, bFGF.was only fotmd in the con- 
ditioned medium, indict ing .:that it is actively se- 
creted from hum£n.SMesii~-:vitm.: PDGF is a potent 
chemotactic ytoldne and a"-m0dest mitogen for 
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Fig. 2. Temporal induction ofCL-1 mRNA by nicotine (A) and cotinine (B). Human SMCs 
were exposed to nicotine or cotinine in concentrations of I0 -8 and I0 -r mol/L dissolved in 
albumin medium for times indicated (6 to 36 hours). Northern blot analysi s(10 ~g of total RNA 
per lane) was performed with CL-1 eDNA probe. Blots were analyzed by autoracliography and 
quantitated by phosphor-imaging techniques, mRNA levels were normalized with TH probe 
and compared with levels in simultaneously analyzed control cells (exposed to albumin medi- 
um). Values represent mean of two to four experiments with SEM indicated by ~,ertical bars. 
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Fig. 3. Temporal induction ofSTM-I mRNA by nicotine (A) and cotinine (B). Human SMCs 
were exposed to nicotine or cotinine in concentrations of 10 -8 and 10 -7 mol/L dissolved in 
albumin medium for times indicated (6 to 36 hours). Northern blot analysis (10 Ixg of total RNA 
per lane) was performed with STM- 1 cDNA probe. Blots were analyzed by autoradiography and 
quantitated by phosphor-imaging techniques, mRNA levels were normalized with TPI probe 
and compared with levels in simultaneously analyzed control cells (exposed to albumin medi- 
um). Values represent mean of two to four experiments with SEM indicated by vertical bars. 
SMCs. It is produced or stored as AA, AB, or BB 
dimeric isoforms by platelets, endothelial cells, mac- 
rophages/monocytes,  and vascular SMCs. 3 The an- 
tibody in the ELISA kit used in the study reacts with 
all three isoforms o f  PDGF. We were unable to detect 
any significant amount o f  PDGF in conditioned me- 
dia or cell lysates of  both the control and treated ceils, 
which could be attributed to the low sensitivity of the 
ELISA kit used. 
The role ofTGF-[3 in the disease o f  vascular wall is 
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Fig. 4. Northern blots of TPI and STM-1 mRNA expression i duced by nicotine (A) and 
cotinine (B). Human SMCs were xposed to nicotine or cotinine (10 -8 tool/L) for 6, 12, 18, 
24, and 36 hours. Each lane corresponds toone time point. Top rows represent TPI expression 
and bottom rows correspond to STM-1. mRNA levels were normalized with TPI probe and 
compared with levels in simultaneously analyzed control cells. 
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Fig. 5. Temporal induction of gelatinase A mRNA by nicotine (A) and cotinine (B). Human 
SMCs were exposed to nicotine or cotinine in concentrations of 10- s and 10-r mol/L dissolved 
in albumin medium for times indicated (6 to 36 hours). Northern blot analysis (10 txg of total 
RNA per lane) was performed with gelatinase A cDNA probe. Blots were analyzed by autora- 
diography and quantitated by phosphor-imaging techniques, mRNA levels were normalized 
with TPI probe and compared with levels in simultaneously analyzed control cells (exposed to 
albumin medium). Values represents mean of two to four experiments with SEM indicated by 
vertical bars. 
not clear. TGF-[3 is involved fia the regulation of  
ECM formation and is also a chemotactic agent for 
macrophages, neutrophils, and fibroblasts. 32,33 It 
may promote or inhibit SMC proliferation in vitro, 
depending on cell density. 32 In our experiments, 
TGF-p was not found in the control, nicotine- 
treated, or cotinine-treated SMCs. TNF-c~, which is 
known to be involved in inflammatory eactions, was 
found in trace amounts in conditioned media and cell 
lysate of both the control and treated cells. These 
results suggest hat TGF-p and the TNF-~ found in 
atherosclerotic plaques are of  macrophage or endo- 
thelial origins. 
MMPs are required for remodeling of  the ECM 
and SMC migration from the media to the intima. 
Nicotine and cotinine affected the expression of  
CL-1, gelatinase A, and STM-1 mRNAs. Nicotine 
significantly stimulated the expression of  CL-1 
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mRNA;  however,  the most  dramatic increase (29- 
fold) was seen in SMCs that were st imulated by 
cot inine at 10 -7 mol /L .  STM-1 specifically digests 
the basement membrane and the internal elastic lam- 
ina, al lowing SMC migrat ion.  STMq levels peaked 
between 12 and 18 hours and were significantly 
inf luenced by the presence of  nicotine and cotinine. 
Gelatinase A up-regulat ion by nicot ine and cotinine 
fol lowed a cyclical pattern with peaks at 12 and 24 
hours. Gelatinase B, a type IV collagenase that is 
secreted by hematopoiet ic  ells, osteoblasts, bone 
marrow ceils and tumor  cells, is known to share many 
protease fianctions with gelatinase A. Our  study indi- 
cates that gelatinase B is not  expressed in human 
SMCs in vitro. 
Most  o f  the experimental  work  related to the role 
o f  MMPs  in the deve lopment  o f  int imal hyperplasia 
has been per formed in the rat carotid artery injury 
model .  1,2~s,34-36 Zempo et al. 35 and Bendeck et al. 36 
reported that gelatinase A and B were up-regulated 
after carotid injury. The discrepancy in the pattern o f  
MMP expression in our experiments and the rat 
carotid injury mode l  can be explained by the differ- 
ence in the experimental  model  (in vitro vs in vivo 
studies), as well as species differences. 
CONCLUSION 
The present studies have demonstrated that nic- 
ot ine and cot inine are potent  regulators o f  bFGF and 
MMP synthesis in human vascular SMCs. Thus ciga- 
rette smoking may play an important  role in the 
deve lopment  o f  restenosis after vascular econstruc- 
t ion and in aneurysmal format ion These findings are 
also important  with regard to the recently introduced 
nicotine gums, sprays, and patches as integral part o f  
smoking cessation therapies. That  is, the use of  these 
products according to manufacturer recommenda-  
t ions may result in nicot ine and cotinine serum con- 
centrations that are comparable with those seen 
among active smokers. 3r-a9 These types of  smoking 
substitutes will probably  decrease the incidence o f  
lung disease that results f rom smoking cigarettes; 
however,  they may still have significant negative ef- 
fects on the cardiovascular system. 
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DISCUSSION 
Dr. Jon R. Cohen (New Hyde Park, N.Y.). I would 
-like to congratulate Dr. Dryjsld for an excellent presenta- 
tion of an elegant study that demonstrates two very signif- 
icant mechanisms whereby smoldng may contribute to the 
development ofintimal hyperplasia and subsequent athero- 
sclerosis. Specifically, nicotine and cotinine enhance the 
production of bFGF, which is essential for medial SMC 
proliferation; and second, metalloproteinases, including 
stromelysin, collagenase, and gelatinase A, were all signifi- 
cantly up-regulated bynicotine and corinne. These metal/ 
loproteinases are thought to be required for the remodeling 
of the ECM, thereby helping the smooth muscle passage 
through the internal elastic lamina. 
I have several questions for the authors. First, does the 
concentration f nicotine and cotflaine correspond to the 
plasma levels that are achieved in smokers? How many 
packs a day does a person have to smoke to have these 
effects correlate with those that are seen in cell culture? 
Furthermore, does the number of cigarettes per day in- 
crease the effects that are seen, or does a certain level get 
achieved after which it doesn't make any further difference? 
Second, the distribution of the effects of collagenase, 
stromelysin, and gelatinase A were all different. Why are 
these effects temporally related, and how do they account 
for the differences in the three metalloenzymes? 
Third, at high concentrations the expression of the 
bFGF and the messenger RNA of the enzymes tested are 
lower. Could this effect be caused by the death of the cells 
as a result of the toxic effects of the agents? To clarify this 
issue, it might have been helpful to have some information 
that would indicate the number of live, intact cells that were 
available at the end of the assay. 
Fourth, from a clinical sense one has to question, then, 
the role of nicotine gum, spray, or patches compared with 
inhalation agents. Converting smokers from inhalation will 
undoubtedly decrease the rate of head, neck, and lung 
cancers; however, the beneficial effects that we would see as 
vascular surgeons might be zero if the metabolism ofnico- 
tine in sprays, gums, or patches i the same as when inhaled. 
Would you comment on what you think the roles of these 
agents will be for the practicing vascular surgeon. 
Once again, I congratulate he authors on an excellent 
study, which I believe provides essential information about 
the mechanisms of the effect of smoking on SMC prolifer- 
ation. 
Dr. Madej Dryjsld. To answer your first question, 
how many cigarettes need to be smoked to achieve nicotine 
and cotinine levels that increase bFGF and MMPs, as I 
mentioned, the concentrations that have the pharmaco- 
logic effect were seen even among the passive smokers, 
JOURNAL OF VASCULAR SURGERY 
Volume 24, Number 6 Carry ev al. 935 
which means that a very small amount of nicotine is neces- 
sary to see these biologic effects. Cotinine. which has a 
prolonged biologic half-life, was more acnve than nicotine. 
So I would assume that passive smoking could affect the 
expression of MMPs and bFGF. 
Answering your question regarding the t mporal ex- 
pression of MMPs, we normalized our results to TPI and to 
the cells exposed only for albumins. What we have seen was 
different emporal expression of MMPs even in the cells 
that were not exposed to nicotine or cotinine. It means that 
these MMPs are expressed differently, with several peaks 
during the 36-hour incubation time. 
Your question regarding the nicotine gum and the 
spray is very important because I believe that all of these 
agents that are used instead of cigarette smoking have the 
same effect as cigarette smoking in terms of the develop- 
ment of intimal hyperplasia. A recently published study 
discussed the levels of nicotine and cotinine in plasma fter 
the use of nicotine gum, and showed that they reached a
concentration f 10 -7 mol/L,  the level pharmacologically 
active in terms of secretion of growth factors and MMPs, in 
our system. As you've mentioned, cigarette smoke has 
several other effects such as increasing the risk of lung 
cancer, which maybe is lower when that gum is used: 
however, in terms of cardiovascular effects, I think that it is 
as bad as smoking. 
Dr. Peter J. Pappas (Newark. N.J. ~ I really enjoyed 
hearing about your study, but there are a few issues on the 
methods that you used that I 'm a little confused about. You 
stated in your dose-response experiments hat you looked 
at three doses of nicotine and cotinine, and then you 
collected the supernarants for 24 hours and then analyzed 
them for bFGF. Did you analyze the other cytoldnes also at 
that time period with the various doses? 
Dr. Dryjski. Yes, we analyzed all growth factors with 
various concentrations of cotinine and nicotine. 
Dr. Pappas. So each cytokine was analyzed at the 
various doses? 
Dr. Dryjsld. Yes, they were analyzed in various doses. 
but the most effective concentrations were l0 7 10-8 
mol/L. 
Dr. Pappas. If I 'm not mistaken, though, you only 
analyzed them for 24 hours, right? You didn't ake them 
out for 24, 48, 72, and perform a true time course experi- 
ment: is that correct? 
Dr. Dryjsld. No. we just analyzed them after 24 hours. 
The assumption was that if the gro~h factors are synthe- 
sized and released from the cells, they probably will remain 
in supernatanr unchanged. The time period of 24 hours is 
long enough to accumulate hese growth factors. 
Dr. Pappas. Well, that's where I take difference with 
you. Because presumably your nicotine and your cotinine 
are stimulating these cells or up-regulating the enzymes to 
produce the cytokines that you're looking at. Also, you 
used Northern blot analysis to try to analyze the production 
of mRNA and that may take 24 to 48 to 72 hours, depend- 
ing on which cytokine that you look at. For instance, 
intetleukin-I can be up-regulated in 6 hours, whereas 
TGF-[3 may not be up-regulated for 48 hours. So I noticed 
that in your presentation you used 72 hours as the nine 
point at which you analyzed a lot of these effects, and I was 
wondering how you came up with 72 hours as your time 
point, because on the basis of your dose-response experi- 
ments you only took it out to 24 hours and you really didn't 
do a true time course experiment. 
Dr. Dryjski. In terms of growth factor, no: but we did 
not analyze mRNA expression for growth factors, we per- 
formed the ELISA assay. 
Dr. Pappas, To analyze the supernatants? 
Dr. Dryjski. The supernatants and cell [ysates. The 
growth factors accumulated either in cell lysates or were 
secreted; for instance, there was no bFGF in the cell lysate, 
all bFGF produced was found in the supematant In terms 
of MMPs, we look on expression ofmRNA, and that's why 
we had to have several time points because mRNA is very 
unstable and degrades. 
